Suppr超能文献

胰岛素瘤的C肽抑制试验。

C-peptide suppression test for insulinoma.

作者信息

Service F J, Horwitz D L, Rubenstein A H, Kuzuya H, Mako M E, Reynolds C, Molnar G D

出版信息

J Lab Clin Med. 1977 Jul;90(1):180-6.

PMID:194989
Abstract

During hypoglycemia induced by an infusion of porcine insulin, impaired suppression of endogenous insulin secretion as measured by C-peptide was demonstrated in 11 of 12 patients with insulinoma. During hypoglycemia (plasma glucose less than or equal to 40 mg/dl) the mean C-peptide immunoreactivity (CPR) of normal subjects was less than or equal to 1.2 ng/ml, whereas 11 of 12 insulinoma patients had a mean CPR of larger than or equal to 1.9 ng/ml. One patient showed normal CPR suppression by these criteria but may have shown impaired CPR suppression for glucose less than or equal to 30 mg/dl. Impaired CPR suppression during insulin-induced hypoglycemia may prove to be a useful test for insulinoma.

摘要

在输注猪胰岛素诱发低血糖期间,12例胰岛素瘤患者中有11例表现出内源性胰岛素分泌抑制受损,这是通过C肽测定的。在低血糖期间(血浆葡萄糖小于或等于40mg/dl),正常受试者的平均C肽免疫反应性(CPR)小于或等于1.2ng/ml,而12例胰岛素瘤患者中有11例的平均CPR大于或等于1.9ng/ml。根据这些标准,有1例患者显示CPR抑制正常,但对于葡萄糖小于或等于30mg/dl的情况,可能显示出CPR抑制受损。胰岛素诱发低血糖期间CPR抑制受损可能被证明是一种用于诊断胰岛素瘤的有用检测方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验